checkAd

     129  0 Kommentare Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device - Seite 3

    FOR FURTHER INFORMATION, please visit the company’s website at www.positron.com, or contact: investor@positron.com


    Investor Relations Contact:
    Skyline Corporate Communications Group, LLC
    Lisa Gray, Senior Account Manager
    One Rockefeller Plaza, 11th Floor
    New York, NY 10020
    Office: (646) 893-5835
    Email: lisa@skylineccg.com


    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device - Seite 3 Niagara Falls, NY, Sept. 08, 2023 (GLOBE NEWSWIRE) - Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that the Company will begin its clinical study of its …